Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
24-Hour IOP and BP Control in Glaucoma and Ocular Hypertension Patients
NCT00330577Phase 4Completed
- Sponsor
- Aristotle University of Thessaloniki
- Start
- Apr 2006
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of latanoprost + timolol in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Aristotle University of Thessaloniki. Started Apr 2006; status: completed.
02
Drugs
latanoprost + timolol
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT00330577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00330577.